Cargando…
Partial response to Chinese patent medicine Kangliu pill for adult glioblastoma: A case report and review of the literature
BACKGROUND: Glioblastoma is the most common type of brain tumor and is invariably fatal, with a mean survival time of 8-15 mo for recently diagnosed tumors, and a 5-year survival rate of only 7.2%. The standard treatment for newly diagnosed glioblastoma includes surgery followed by concurrent chemor...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058673/ https://www.ncbi.nlm.nih.gov/pubmed/33969068 http://dx.doi.org/10.12998/wjcc.v9.i12.2845 |